Pharmafile Logo

Research and Development

- PMLiVE

Amiculum joins Bionow: supporting collaboration across the life sciences sector in the North of the UK

We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role in bringing together life sciences organizations across the North of the...

Amiculum

- PMLiVE

Amiculum reaffirms presence in Dundee with new office and continued academic partnership

Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment designed to accelerate scientific progress...

Amiculum

- PMLiVE

British Chambers of Commerce partners with Singapore to scale up UK imports

The Singapore Life Sciences Trade Accelerator six-month pilot programme aims to increase export opportunities

- PMLiVE

New centre for life sciences launched in London

Victoria House is a state-of-the-art life sciences hub

- PMLiVE

NHS programme to give head and neck cancer patients fast-track access to mRNA vaccine

More than 11,000 people are diagnosed with head and neck cancers every year in England

- PMLiVE

UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

- PMLiVE

BioNTech expands mRNA capabilities with $1.25bn CureVac acquisition

The deal will support the advancement of BioNTech’s mRNA-based cancer immunotherapies

- PMLiVE

BMS and BioNTech partner on solid tumour candidate in deal worth over $11bn

BioNTech’s BNT327 is being evaluated in multiple clinical trials, including phase 3 studies in first-line lung cancer

- PMLiVE

BioNTech announces £1bn UK investment to boost regional R&D presence

The UK government has also agreed to award the company a grant of up to £129m

Map Treatment Pathways Virtually – Engaging Your Advisors Creatively

Optimize product strategy! Discover how virtual profiling can accurately map treatment pathways and pinpoint opportunities for your innovations while engaging your advisors in a creative way!

Impetus Digital

- PMLiVE

Sanofi unveils $20bn US investment to boost R&D and manufacturing presence

The company is the latest major drugmaker to announce a significant investment in the country

- PMLiVE

UK government’s AMR study highlights importance of appropriate antibiotic use

The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links